Please assess the completion status of the following clinical trial:

Trial Title: Atorvastatin in Acute Stroke Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Eligible patients were men and women over 18 years of age who had an acute ischemic stroke with a symptom time onset \< 48 hours~Exclusion Criteria:~* Patients with inflammatory or infectious diseases, cancer, hematological diseases and severe renal or liver failure, as well as those who were under treatment with anti-inflammatory were excluded

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- early Atorvastatin treatment (Type: EXPERIMENTAL): Ischemic stroke patients treated with with atorvastatin 80 mg at admission until discharge
- no early treatment with atorvastatin (Type: NO_INTERVENTION): Ischemic stroke patients not treated with with atorvastatin 80 mg until discharge

Based on this trial design, predict the completion outcome and termination type (if applicable).